182 related articles for article (PubMed ID: 20630585)
41. Biological response and cytotoxicity induced by lipid nanocapsules.
Szwed M; Torgersen ML; Kumari RV; Yadava SK; Pust S; Iversen TG; Skotland T; Giri J; Sandvig K
J Nanobiotechnology; 2020 Jan; 18(1):5. PubMed ID: 31907052
[TBL] [Abstract][Full Text] [Related]
42. Fluorescent polyurethane nanocapsules prepared via inverse miniemulsion: surface functionalization for use as biocarriers.
Paiphansiri U; Dausend J; Musyanovych A; Mailänder V; Landfester K
Macromol Biosci; 2009 Jun; 9(6):575-84. PubMed ID: 19180579
[TBL] [Abstract][Full Text] [Related]
43. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery.
Shen Y; Jin E; Zhang B; Murphy CJ; Sui M; Zhao J; Wang J; Tang J; Fan M; Van Kirk E; Murdoch WJ
J Am Chem Soc; 2010 Mar; 132(12):4259-65. PubMed ID: 20218672
[TBL] [Abstract][Full Text] [Related]
44. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation.
Zou J; Saulnier P; Perrier T; Zhang Y; Manninen T; Toppila E; Pyykkö I
J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):10-8. PubMed ID: 18437698
[TBL] [Abstract][Full Text] [Related]
45. Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring.
Lainé AL; Gravier J; Henry M; Sancey L; Béjaud J; Pancani E; Wiber M; Texier I; Coll JL; Benoit JP; Passirani C
J Control Release; 2014 Aug; 188():1-8. PubMed ID: 24878182
[TBL] [Abstract][Full Text] [Related]
46. Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion.
Anton N; Gayet P; Benoit JP; Saulnier P
Int J Pharm; 2007 Nov; 344(1-2):44-52. PubMed ID: 17592746
[TBL] [Abstract][Full Text] [Related]
47. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T
Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405
[TBL] [Abstract][Full Text] [Related]
48. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
49. In vitro drug release mechanism from lipid nanocapsules (LNC).
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Int J Pharm; 2010 May; 390(2):208-13. PubMed ID: 20149853
[TBL] [Abstract][Full Text] [Related]
50. Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles.
Gao X; Wang T; Wu B; Chen J; Chen J; Yue Y; Dai N; Chen H; Jiang X
Biochem Biophys Res Commun; 2008 Dec; 377(1):35-40. PubMed ID: 18823949
[TBL] [Abstract][Full Text] [Related]
51. A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging.
Bastiat G; Pritz CO; Roider C; Fouchet F; Lignières E; Jesacher A; Glueckert R; Ritsch-Marte M; Schrott-Fischer A; Saulnier P; Benoit JP
J Control Release; 2013 Sep; 170(3):334-42. PubMed ID: 23792117
[TBL] [Abstract][Full Text] [Related]
52. Cytotoxicity and genotoxicity of lipid nanocapsules.
Le Roux G; Moche H; Nieto A; Benoit JP; Nesslany F; Lagarce F
Toxicol In Vitro; 2017 Jun; 41():189-199. PubMed ID: 28323104
[TBL] [Abstract][Full Text] [Related]
53. Degradable poly(beta-amino ester) nanoparticles for cancer cytoplasmic drug delivery.
Shen Y; Tang H; Zhan Y; Van Kirk EA; Murdoch WJ
Nanomedicine; 2009 Jun; 5(2):192-201. PubMed ID: 19223244
[TBL] [Abstract][Full Text] [Related]
54. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors.
Douglas KL; Piccirillo CA; Tabrizian M
Eur J Pharm Biopharm; 2008 Mar; 68(3):676-87. PubMed ID: 17945472
[TBL] [Abstract][Full Text] [Related]
55. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide.
Karim R; Lepeltier E; Esnault L; Pigeon P; Lemaire L; Lépinoux-Chambaud C; Clere N; Jaouen G; Eyer J; Piel G; Passirani C
Nanoscale; 2018 Jul; 10(28):13485-13501. PubMed ID: 29972178
[TBL] [Abstract][Full Text] [Related]
56. Formulation and characterization of polyphenol-loaded lipid nanocapsules.
Barras A; Mezzetti A; Richard A; Lazzaroni S; Roux S; Melnyk P; Betbeder D; Monfilliette-Dupont N
Int J Pharm; 2009 Sep; 379(2):270-7. PubMed ID: 19501139
[TBL] [Abstract][Full Text] [Related]
57. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
58. In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel.
Lacoeuille F; Hindre F; Moal F; Roux J; Passirani C; Couturier O; Cales P; Le Jeune JJ; Lamprecht A; Benoit JP
Int J Pharm; 2007 Nov; 344(1-2):143-9. PubMed ID: 17646066
[TBL] [Abstract][Full Text] [Related]
59. Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules.
Scheper V; Wolf M; Scholl M; Kadlecova Z; Perrier T; Klok HA; Saulnier P; Lenarz T; Stöver T
Nanomedicine (Lond); 2009 Aug; 4(6):623-35. PubMed ID: 19663591
[TBL] [Abstract][Full Text] [Related]
60. Entrance effects at nanopores of nanocapsules functionalized with poly(ethylene glycol) and their flow through nanochannels.
Popa R; Vrânceanu M; Nikolaus S; Nirschl H; Leneweit G
Langmuir; 2008 Nov; 24(22):13030-6. PubMed ID: 18950201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
